Fundamentals data is not available for this company.
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-12 | 918.90 | 203.93 | 168.21¢ | 23.7 | 0.1 | +224% | n/a | 0.0% |
| 31-Dec-13 | 1,009.74 | 244.61 | 178.86¢ | 22.3 | 3.5 | +6% | n/a | 0.0% |
Copyright © 2012 FactSet Research Systems Inc. All rights reserved.
No recent information was found.
| Test Results Reported on New Antibiotic | 04-Apr-2001 | New York Times |
| Currency | US Dollars |
| Share Price | $ 39.87 |
| Change Today | $ -0.04 |
| % Change | -0.10 % |
| 52 Week High | $44.72 |
| 52 Week Low | $29.59 |
| Volume | 303,156 |
| Shares Issued | 63.34m |
| Market Cap | $2,525.26m |
| Beta | 0.91 |
| RiskGrade | 113 |
| Strong Buy | 9 |
| Buy | 1 |
| Neutral | 4 |
| Sell | 0 |
| Strong Sell | 1 |
| Total | 15 |

| Time | Volume / Share Price |
| 16:00 | 46,017 @ $39.87 |
| 15:59 | 200 @ $39.87 |
| 15:59 | 100 @ $39.87 |
| 15:59 | 200 @ $39.87 |
| 15:59 | 476 @ $39.87 |
You are here: research